Showing results (181-190 of 194) with videos related to
Sort By:
Pageof 20
The American Journal of Pathology|February 1, 1997
Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaquesE MeinL, R M Hoch, K Dornmair, et al.Brain, Behavior, and Immunity|May 31, 2011
BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesionsM Kipp, S Gingele, F Pott, et al.Deutsche Medizinische Wochenschrift (1946)|May 6, 1983
[Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters]H Grosse-Wilde, K V Toyka, U A Besinger, et al.Multiple Sclerosis and Related Disorders|February 4, 2019
Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosisS Grahl, V Pongratz, P Schmidt, et al.Journal of Neuroimmunology|March 10, 2001
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controlsC G Haase, J Guggenmos, U Brehm, et al.Journal of Neuroimmunology|September 11, 2007
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesionsM Krumbholz, D Theil, F Steinmeyer, et al.The Journal of Experimental Medicine|March 2, 1999
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?M Kerschensteiner, E Gallmeier, L Behrens, et al.Brain : a Journal of Neurology|July 17, 2009
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosisS Cotte, N von Ahsen, N Kruse, et al.Journal of Neuroinflammation|December 17, 2015
Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MSL Schrewe, C M Lill, T Liu, et al.European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.Pageof 20